European Companies Search Engine
EU funding (€6,155,125): A Clinical Phase IIB trial with 2OHOA in patients with newly-diagnosed malignant glioma. Hor 1 Dec 2017 EU Research and Innovation programme "Horizon"
Overview
Text
This publication is not available.
The filing refers to a past date, and does not necessarily reflect the current state.